Enliven Therapeutics Inc Com Gains 38.77%

Tue, Mar 19, 2024 at 07:28 PM
Enliven Therapeutics Inc Com Gains 38.77%

Enliven Therapeutics Inc Com (ELVN:NASDAQ) rocketted at $17.54, representing a gain of 38.8%. On Tue, Mar 19, 2024, ELVN:NASDAQ hit a New 2-Week High of $17.54. The stock appeared on our News Catalysts scanner on Tue, Mar 19, 2024 at 11:02 AM in the 'PRIVATE PLACEMENT' category. From Tue, Mar 05, 2024, the stock recorded 30.00% Up Days and 27.27% Green Days

About Enliven Therapeutics Inc Com (ELVN:NASDAQ)

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially best-in-class or first-in-class precision oncology therapies.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.